Gossamer Bio, Inc. (GOSS)
0.1762
+0.02
(+13.90%)
USD |
NASDAQ |
Aug 24, 16:00
0.1699
-0.01
(-3.58%)
After-Hours: 20:00
Gossamer Bio Shareholders Equity (Quarterly) : -94.03M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -94.03M |
| March 31, 2026 | -161.48M |
| December 31, 2025 | -122.76M |
| September 30, 2025 | -82.33M |
| June 30, 2025 | -46.11M |
| March 31, 2025 | -6.25M |
| December 31, 2024 | 29.49M |
| September 30, 2024 | 54.14M |
| June 30, 2024 | 81.53M |
| March 31, 2024 | 26.72M |
| December 31, 2023 | 62.77M |
| September 30, 2023 | 104.62M |
| June 30, 2023 | -62.80M |
| March 31, 2023 | -28.46M |
| December 31, 2022 | 12.08M |
| September 30, 2022 | 56.35M |
| June 30, 2022 | -16.46M |
| March 31, 2022 | 30.16M |
| Date | Value |
|---|---|
| December 31, 2021 | 121.46M |
| September 30, 2021 | 169.81M |
| June 30, 2021 | 220.69M |
| March 31, 2021 | 272.08M |
| December 31, 2020 | 320.68M |
| September 30, 2020 | 372.10M |
| June 30, 2020 | 420.32M |
| March 31, 2020 | 306.46M |
| December 31, 2019 | 352.48M |
| September 30, 2019 | 398.87M |
| June 30, 2019 | 441.44M |
| March 31, 2019 | 480.26M |
| December 31, 2018 | 218.30M |
| September 30, 2018 | 246.59M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -6.862M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| United Therapeutics Corp. | 6.400B |
| Arbutus Biopharma Corp. | 258.73M |
| Kura Oncology, Inc. | 48.43M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.87M |
| Total Liabilities (Quarterly) | 170.90M |
| Debt to Equity Ratio | -0.4261 |
| Current Ratio | 0.5278 |
| Net Debt Paydown Yield | 40.45% |